In Vivo Generation of CAR T Cells Selectively in Human CD4+ Lymphocytes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In Vivo Generation of CAR T Cells Selectively in Human CD4+ Lymphocytes

Published:2020-08 Issue:8 Volume:28 Page:1783-1794
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Agarwal Shiwani,Hanauer Julia D.S.,Frank Annika M.,Riechert Vanessa,Thalheimer Frederic B.,Buchholz Christian J.

Funder

Bundesministerium für Gesundheit

Deutsche Krebshilfe

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference25 articles.

1. CAR T cell immunotherapy for human cancer;June;Science,2018

2. Chimeric antigen receptors: a paradigm shift in immunotherapy;Sadelain;Annu. Rev. Cancer Biol.,2017

3. Design and development of therapies using chimeric antigen receptor-expressing T cells;Dotti;Immunol. Rev.,2014

4. CAR T-cell therapy: a new era in cancer immunotherapy;Miliotou;Curr. Pharm. Biotechnol.,2018

5. Clinical development of CAR T cells-challenges and opportunities in translating innovative treatment concepts;Hartmann;EMBO Mol. Med.,2017

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo CAR T cell therapy against angioimmunoblastic T cell lymphoma;Journal of Experimental & Clinical Cancer Research;2024-09-14

2. Advancing CAR T-cell therapies: Preclinical insights and clinical translation for hematological malignancies;Blood Reviews;2024-09

3. In vivo CAR T-cell generation in nonhuman primates using lentiviral vectors displaying a multidomain fusion ligand;Blood;2024-08-29

4. Advances in manufacturing chimeric antigen receptor immune cell therapies;Seminars in Immunopathology;2024-08-16

5. Advancements and challenges in developing in vivo CAR T cell therapies for cancer treatment;eBioMedicine;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3